What We're Reading: Page 154
Industry reads hand-picked by our editors
Jul 06, 2021
-
Axios
Physicians will feel pressure as gatekeepers of Aduhelm
-
The Wall Street Journal
Midsize Pharmaceutical Firms Are the Industry's Big Deal Makers This Year
-
Endpoints News
Bob Nelsen is building a really big neuroscience company
-
Evaluate Vantage
Biopharma takeovers dry up
Jul 02, 2021
-
The Atlantic
The Danger of Delta Holds to 3 Simple Rules
-
Reuters
Novartis weighs entry into mRNA technology, chairman tells paper
-
The Wall Street Journal
GlaxoSmithKline Says Board Supports Under-Pressure CEO
-
Science
Scientists quit journal board, protesting ‘grossly irresponsible’ study claiming COVID-19 vaccines kill
Jul 01, 2021
Jun 30, 2021
-
The New York Times
Mixing Pfizer, AstraZeneca Vaccines Gives Strong Covid Protection, Study Finds
-
Kaiser Health News
States Step Up Push to Regulate Pharmacy Drug Brokers
-
The Wall Street Journal
Why Vaccinated Athletes Are Testing Positive for Coronavirus
Jun 29, 2021
Jun 28, 2021
-
The Wall Street Journal
Johnson & Johnson Settles New York Opioid Case for $230 Million
-
The Atlantic
The mRNA Vaccines Are Extraordinary, but Novavax Is Even Better
-
FierceBiotech
AstraZeneca names Galbraith as Baselga successor in cancer R&D
-
Reuters
Idorsia to trial self-injection drug for heart attack victims
Previous
